Susan Lee
Professional Bio
Susan Lee’s practice focuses on the U.S. Food and Drug Administration’s regulation of pharmaceuticals and biological products. Susan counsels clients on a broad range of FDA legal and regulatory matters, with particular areas of expertise and interest in advertising and promotion issues; the design and conduct of clinical trials; approval standards for new products; and the FDA-related considerations that arise in the context of acquisitions, collaborations, licensing arrangements, and other types of transactions in the pharmaceutical and biotechnology sector.
FTC takes on deceptive stem cell therapy claims for blindness cure and autism treatment
Focus on Regulation ·
Obtaining FDA clearance or approval of digital health products
Focus on Regulation ·
FDA Clarifies and Expands Eligibility for RMAT Designation for Gene Therapies
Focus on Regulation ·